Holistic Care Services

16/10/2026

Who operates Asia & middle East’s Largest !!!!

15/10/2026

HealthcareMarketResearch

Surgical Devices Market to Reach USD 296.76 Billion by 2031

The global surgical devices market is witnessing strong growth as healthcare providers increasingly adopt minimally invasive procedures, robotic-assisted surgery, and advanced surgical technologies.

✅ Significant Market Growth
The market is projected to grow from USD 188.74 billion in 2026 to USD 296.76 billion by 2031, registering a CAGR of 9.5%.

✅ Primary Growth Drivers
• Rising prevalence of chronic diseases and age-related conditions
• Increasing volume of surgical procedures worldwide
• Growing adoption of minimally invasive and robotic-assisted surgeries
• Expansion of healthcare infrastructure and advanced surgical facilities

✅ Technological Advancements
Robotic surgical systems, advanced endoscopy, energy-based instruments, and improved surgical visualization are transforming operating room capabilities.

✅ Trends & Disruptions Impacting Customers
Hospitals and ambulatory surgery centers are prioritizing technologies that support procedural efficiency, shorter recovery times, infection control, and improved operating room productivity.

✅ Leading Segment Analysis
Implants represent the largest product segment, while hospitals remain the leading end-user segment. North America holds the largest regional share.
Major Companies Shaping the Market

Medtronic, Johnson & Johnson, Intuitive Surgical, Stryker, B. Braun, Olympus Corporation, Boston Scientific, CONMED, Integra LifeSciences, and Smith+Nephew.

05/10/2026

The global market was valued at US$ 16.31 billion in 2024 and is projected to reach US$ 25.69 billion by 2029, growing at a CAGR of 9.5%.

Primary Market Drivers: Demand is driven by an aging global population with a higher incidence of structural heart conditions (e.g., aortic stenosis, mitral regurgitation) and the rapid shift toward minimally invasive procedures.

Leading Product Segment: The heart valve devices segment—specifically Transcatheter Heart Valves (THV)—holds the highest market share and growth rate due to shorter recovery times and less invasive delivery systems.

Dominant Procedure Type: Replacement procedures (such as TAVR and TMVR) outperform repair procedures due to higher versatility, strong clinical efficacy data, and suitability for high-risk surgical candidates.

Key Market Restraints: High procedure costs (TAVR systems can exceed $30,000 per procedure) along with limited reimbursement schemes in lower-income regions create significant barriers to adoption.

Emerging Opportunities: Advancement in tissue-engineered heart valves (TEHVs) using patient-specific cells offers higher biocompatibility and long-term durability, minimizing the need for multiple interventions in younger patients.

Regional Dominance: North America commands the largest regional share due to advanced healthcare infrastructure, high disease prevalence, and rapid adoption of cutting-edge cardiovascular technologies.

03/09/2026

27/08/2026

การจัดการบาดแผลที่มีประสิทธิภาพมีความสําคัญมากขึ้นเรื่อย ๆ เนื่องจากระบบการดูแลสุขภาพจัดการกับภาระที่เพิ่มขึ้นของโรคเรื้อรัง การบาดเจ็บที่บาดแผล กรณีแผลไหม้ และจำนวนผู้ป่วยสูงอายุ

🔬 ข้อมูลทางการตลาดที่สําคัญ:

• ผลิตภัณฑ์ดูแลบาดแผลมีส่วนแบ่งการตลาดค่อนข้างใหญ่

• บาดแผลเรื้อรังส่วนใหญ่เป็นต้นเหตุของการลุกลามเป็นบาดแผลขนาดใหญ่ เริ่มจากแผลเล็กเรื้อรังจนกลายเป็นแผลติดเชื้อขนาดใหญ่

• โรงพยาบาลและคลินิกเป็นกลุ่มที่ต้องการใช้ wound care ที่ใหญ่ที่สุด

• เอเชียแปซิฟิกกําลังมีการเติบโตของตลาด wound care ที่สูงขึ้น

• ความก้าวหน้าทางเทคโนโลยี รวมถึงนวัตกรรมอัจฉริยะและโซลูชันการรักษาบาดแผลกําลังสร้างและพัฒนาไปในทางที่ดีขึ้น

อนาคตของการดูแลบาดแผลมุ่งเน้นไปที่การรักษาที่เร็วขึ้น การป้องกันการติดเชื้อ เน้นความสะดวกสบายของผู้ป่วยที่ดีขึ้น และแนวทางการรักษาที่เป็นส่วนตัวมากขึ้น

ในขณะที่นวัตกรรมก็มีการเปลี่ยนแปลงการจัดการกับบาดแผล ด้วยเทคโนโลยีใหม่ๆซึ่งจะมีบทบาทสําคัญมากขึ้นในโรงพยาบาล คลินิก การดูแลผู้ป่วยที่บ้าน และการดูแลระยะยาว

22/08/2026

𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐭 𝐭𝐨 𝐇𝐢𝐭 𝐔𝐒𝐃 296.76 𝐁. 𝐛𝐲 2031 𝐚𝐭 𝐚 9.5% 𝐂𝐀𝐆𝐑

Market Growth & Valuation: The global surgical devices market is projected to reach $296.76 billion by 2031, up from $188.74 billion in 2026 at a 9.5% CAGR.

Leading Product Segment: Implants (orthopedic, cardiovascular, spinal, etc.) account for the largest market share (30–35%), driven by high unit costs and rising demand.

Dominant End User: Hospitals remain the primary end user, commanding 65–70% of the total market due to their capacity for high-acuity, complex procedures.

Regional Market Leader: North America holds the largest share of the global market (40–45%), supported by advanced infrastructure, high healthcare spending, and rapid adoption of novel surgical tech.

Key Key Growth Drivers: Rising prevalence of chronic diseases, an aging global population, and a accelerating shift toward minimally invasive and robotic-assisted surgeries.

Primary Market Restraint: High initial capital intensity and long equipment replacement cycles especially for robotic and energy platforms constrain adoption in cost-sensitive healthcare settings.

06/08/2026

Medical Devices Market to Reach USD 1,032.6 Billion by 2034 | 6.90% CAGR |

Healthcare is entering a new era where intelligent medical devices are transforming diagnosis, treatment, and patient outcomes.

The is expanding rapidly as innovations in artificial intelligence, robotics, connected healthcare, wearable technologies, and minimally invasive procedures reshape the global healthcare landscape. From hospitals and diagnostic laboratories to ambulatory care centers and home healthcare, advanced medical devices are improving clinical efficiency, enabling personalized care, and supporting better patient outcomes.

📊 Key Market Insights

🫀 Cardiovascular Devices Market is projected to grow from USD 77.71 Billion in 2024 to USD 110.3 Billion by 2029, expanding at a 7.3% CAGR.

🦴 Orthopedic Devices Market is expected to increase from USD 51.6 Billion in 2024 to USD 68.5 Billion by 2030, registering a 4.8% CAGR.

🩸 Diabetes Care Devices Market is forecast to rise from USD 34.3 Billion in 2025 to USD 61.2 Billion by 2030, growing at a 12.3% CAGR.

🩹 Wound Care Market is anticipated to expand from USD 22.2 Billion in 2025 to USD 30.4 Billion by 2030, reflecting a 6.5% CAGR.

🌎 Regional Outlook
North America accounted for 38.1% of the global Medical Devices Market in 2025, supported by advanced healthcare infrastructure, strong R&D investments, favorable reimbursement systems, and the presence of leading medical technology companies.

🧪 Product Spotlight
In-vitro Diagnostics (IVD) continues to lead the product landscape, representing 13.53% of the global market in 2026.

The segment is projected to grow from USD 109.06 Billion in 2025 to USD 157.6 Billion by 2030, at a 7.6% CAGR, driven by rising demand for early disease detection and precision diagnostics.

📈 Key Growth Drivers
✅ Rising prevalence of chronic diseases and aging populations.
✅ Growing adoption of AI-powered diagnostics and digital health technologies.
✅ Increasing demand for minimally invasive and robotic-assisted procedures.
✅ Expansion of remote patient monitoring and wearable medical devices.
✅ Continuous innovation in smart, connected, and data-driven healthcare solutions.

06/08/2026

Top 5 Strategic CAPEX Initiatives

plc – Investment in advanced cardiac surgery technologies, structural heart devices, robotic-assisted surgery, and global manufacturing expansion.

– Capital deployment toward transcatheter heart valve innovation, next-generation surgical technologies & production capacity expansion.

Laboratories – Expansion of electrophysiology, cardiac ablation systems, structural heart solutions & digital cardiovascular platforms.

Johnson & Johnson MedTech – Investment in , advanced &
technologies.

06/08/2026

24/07/2026

The 51 st Annual Scientific Congress of The Royal College of Surgeons of Thailand, held at the Royal Cliff Hotels, Pattaya, Thailand, from July 24 to 26, 2026.

This year, the theme of the meeting is “Toward Best Practices through Collaboration and Integrity”



#แทนคุณbyholisticcare
#ข้าวของพ่อผักของแม่
#ราชวิทยาลัยศัลยแพทย์